PLoS ONE (Jan 2020)

Genome-wide DNA methylation signatures to predict pathologic complete response from combined neoadjuvant chemotherapy with bevacizumab in breast cancer.

  • Ping-Ching Hsu,
  • Susan A Kadlubar,
  • Eric R Siegel,
  • Lora J Rogers,
  • Valentina K Todorova,
  • L Joseph Su,
  • Issam Makhoul

DOI
https://doi.org/10.1371/journal.pone.0230248
Journal volume & issue
Vol. 15, no. 4
p. e0230248

Abstract

Read online

TRIAL REGISTRATION:ClinicalTrials.gov Identifier: NCT00203502.